Tandem jumps on upgrade

|About: Tandem Diabetes Care, ... (TNDM)|By:, SA News Editor

Shares of thinly-traded Tandem Diabetes Care (TNDM +11.9%) pop on turnover of 250K shares after Deutsche Bank raises its rating from Hold to Buy with a $25 PT (down from $28). In March, Sterne Agee initiated coverage with a Neutral rating and $25 PT.

Consensus revenue targets for Q2 and Q3 are $11M and $14.1M, respectively.

Consensus views for 2014 and 2015 revenues are $51.7M and $83.6M, respectively.

Since its debut in November 124 mutual funds have bought in.